Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

• Status: Completed
• Trial end date: 2017-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy and safety of OPA-15406 ointment in patients with atopic dermatitis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Otsuka Pharmaceutical Co., Ltd.

Criteria

Inclusion Criteria:

• Diagnosis of atopic dermatitis based on the criteria of Hanifin and Rajka

Exclusion Criteria:

• Subjects who have an atopic dermatitis or contact dermatitis flare-up defined as a sudden intensification of atopic dermatitis.

• Subjects who have an active viral skin infection.

• Subjects with a current or history of malignancy.